Novel BRCA2 pathogenic genotype and breast cancer phenotype discordance in monozygotic triplets

Hladikova, 2013, [Breast cancer in monozygotic twins], Klin. Onkol., 26, 213, 10.14735/amko2013213 Kuchenbaecker, 2017, Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers, J. Am. Med. Assoc., 317, 2402, 10.1001/jama.2017.7112 Mack, 2002, Heritable breast cancer in twins, Br. J. Canc., 87, 294, 10.1038/sj.bjc.6600429 Mavaddat, 2013, Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE, J. Natl. Cancer Inst., 105, 812, 10.1093/jnci/djt095 Michailidou, 2013, Large-scale genotyping identifies 41 new loci associated with breast cancer risk, Nat. Genet., 45, 353, 10.1038/ng.2563 Miki, 1994, A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1, Science, 266, 66, 10.1126/science.7545954 Nielsen, 2016, BRCA1/BRCA2 founder mutations and cancer risks: impact in the western Danish population, Fam. Cancer, 15, 507, 10.1007/s10689-016-9875-7 Richards, 2015, Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology, Genet. Med., 17, 405, 10.1038/gim.2015.30 Tung, 2018, BRCA1/2 testing: therapeutic implications for breast cancer management, Br. J. Canc., 119, 141, 10.1038/s41416-018-0127-5 Wooster, 1995, Identification of the breast cancer susceptibility gene BRCA2, Nature, 378, 789, 10.1038/378789a0